Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Aurobindo Pharma Ltd.
NSE: AUROPHARMA
|
BSE: 524804
|
ISIN: INE406A01037
|
Industry: Pharmaceuticals
US FDA Approval
|
Value Stock, Under Radar
1121.0000
38.55
(
3.56
%)
NSE
Apr 15, 2025
11:47 AM
29.59% Fall from 52W High
Volume:
603.5K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Aurobindo Pharma Ltd.
19 Nov 2024
US FDA Approval
1121.00
3.56%
Aurobindo Pharma Limited
Buy:
Aurobindo Pharma Ltd.
by
ICICI Direct
Target: 1580 | Upside : 40.9%
Target
ICICI Direct
Aurobindo Pharma Ltd. is trading
below its 50 day SMA
of 1134.4
More from Aurobindo Pharma Ltd.
Recommended
Market trades higher, Persistent Systems gets NCLT approval to merge with its subsidiary
Trendlyne Marketwatch |
15 Apr 2025, 11:44AM
Five Interesting Stocks Today - April 11, 2025
The Baseline |
11 Apr 2025
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
|
15 Jul 2020